20 May 2013
Keywords: barr, confirms, patent, challenge, novartis, ritalin, generics
Article | 12 November 2007
US generics firm Barr Laboratories says it has initiated a challenge of the patents listed by Novartis Pharmaceuticals in connection ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.